Grey Fox Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,705
Closed -$238K 180
2026
Q1
$238K Buy
1,705
+26
+2% +$3.64K 0.05% 127
2025
Q4
$206K Sell
1,679
-447
-21% -$54.3K 0.04% 131
2025
Q3
$236K Sell
2,126
-4
-0.2% -$455 0.05% 129
2025
Q2
$236K Sell
2,130
-160
-7% -$17K 0.06% 118
2025
Q1
$257K Buy
2,290
+5
+0.2% +$516 0.07% 110
2024
Q4
$211K Buy
+2,285
New +$206K 0.06% 122
2024
Q2
Sell
-3,006
Closed -$220K 129
2024
Q1
$220K Sell
3,006
-157
-5% -$12.1K 0.08% 118
2023
Q4
$256K Sell
3,163
-167
-5% -$13K 0.11% 92
2023
Q3
$250K Buy
3,330
+9
+0.3% +$692 0.13% 92
2023
Q2
$256K Sell
3,321
-2,464
-43% -$197K 0.13% 87
2023
Q1
$480K Sell
5,785
-293
-5% -$24.3K 0.28% 57
2022
Q4
$522K Buy
+6,078
New +$481K 0.34% 49

Other funds holding GILD

Grey Fox Wealth Advisors's GILD Position: Q2 2026 in Review

Grey Fox Wealth Advisors sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,705 shares — an estimated $238K sold.

Grey Fox Wealth Advisors first reported a position in GILD in Q4 2022 and held it in 12 quarters. The position peaked at $522K in Q4 2022. 536 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Grey Fox Wealth Advisors reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Grey Fox Wealth Advisors sold 1,705 Gilead Sciences shares in Q2 2026, an estimated $238K.
  • Grey Fox Wealth Advisors first reported a position in Gilead Sciences in Q4 2022 and held it in 12 quarters.
  • Grey Fox Wealth Advisors's Gilead Sciences position peaked at $522K in Q4 2022.
  • 536 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Grey Fox Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.